| Results summary | View all lists in GO:MoleFunc | View all genes in C05AA.profile.ud50 |
|
Interacting selectively with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). enrichment: 1.22-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 210967_X_AT | CACNB1 | T | calcium channel, voltage-dependent, beta 1 subunit | ||||||||||
| 214786_AT | MAP3K1 | G | X | P | S | mitogen-activated protein kinase kinase kinase 1 | |||||||
| 218502_S_AT | TRPS1 | T | D | R | trichorhinophalangeal syndrome I | ||||||||
| 212185_X_AT | MT2A | metallothionein 2A | |||||||||||
| 215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 205440_S_AT | NPY1R | E | S | neuropeptide Y receptor Y1 | |||||||||
| 203961_AT | NEBL | T | nebulette | ||||||||||
| 217997_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
| 212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
| 202861_AT | PER1 | R | S | period homolog 1 (Drosophila) | |||||||||
| 203962_S_AT | NEBL | T | nebulette | ||||||||||
| 214439_X_AT | BIN1 | G | T | D | bridging integrator 1 | ||||||||
| 217427_S_AT | HIRA | D | R | HIR histone cell cycle regulation defective homolog A (S. cerevisiae) | |||||||||
| 205945_AT | IL6R | G | D | X | S | interleukin 6 receptor | |||||||
| 215990_S_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 203358_S_AT | EZH2 | D | P | R | enhancer of zeste homolog 2 (Drosophila) | ||||||||
| 203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
| 209373_AT | MALL | mal, T-cell differentiation protein-like | |||||||||||
| 209304_X_AT | GADD45B | G | D | X | S | growth arrest and DNA-damage-inducible, beta | |||||||
| 207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 221012_S_AT | TRIM8 | tripartite motif-containing 8 | |||||||||||
| 201041_S_AT | DUSP1 | X | E | P | dual specificity phosphatase 1 | ||||||||
| 212593_S_AT | PDCD4 | G | R | programmed cell death 4 (neoplastic transformation inhibitor) | |||||||||
| 201389_AT | ITGA5 | C | S | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | |||||||||
| 211082_X_AT | MARK2 | D | P | S | MAP/microtubule affinity-regulating kinase 2 | ||||||||
| 204560_AT | FKBP5 | P | FK506 binding protein 5 | ||||||||||
| 36829_AT | PER1 | R | S | period homolog 1 (Drosophila) | |||||||||
| 201945_AT | FURIN | P | C | furin (paired basic amino acid cleaving enzyme) | |||||||||
| 200878_AT | EPAS1 | D | X | R | S | endothelial PAS domain protein 1 | |||||||
| 221009_S_AT | ANGPTL4 | G | D | X | E | S | angiopoietin-like 4 | ||||||
| 205409_AT | FOSL2 | R | FOS-like antigen 2 | ||||||||||
| 218559_S_AT | MAFB | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | |||||||||
| 210059_S_AT | MAPK13 | X | P | S | mitogen-activated protein kinase 13 | ||||||||
| 202725_AT | POLR2A | R | polymerase (RNA) II (DNA directed) polypeptide A, 220kDa | ||||||||||
| 209635_AT | AP1S1 | T | adaptor-related protein complex 1, sigma 1 subunit | ||||||||||
| 204589_AT | NUAK1 | P | NUAK family, SNF1-like kinase, 1 | ||||||||||
| 203439_S_AT | STC2 | C | S | stanniocalcin 2 | |||||||||
| 37152_AT | PPARD | G | T | D | E | R | C | S | peroxisome proliferator-activated receptor delta | ||||
| 201341_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
| 208937_S_AT | ID1 | D | R | S | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | ||||||||
| 205067_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||
| 209120_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 203017_S_AT | SSX2IP | C | synovial sarcoma, X breakpoint 2 interacting protein | ||||||||||
| 206411_S_AT | ABL2 | P | C | S | v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) | ||||||||
| 201340_S_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
| 211833_S_AT | BAX | G | T | D | X | P | S | BCL2-associated X protein | |||||